While APP and its processing to amyloid beta (Aβ) have been more extensively studied in AD, the protein is also reported to be expressed ubiquitously by neuronal and non-neuronal cells with frequent overexpression in multiple cancers including lung, prostate, colon, breast, glioblastoma, and pancreatic cancer, driving cancer cell proliferation [7,10]. Here, APP is linked to Alzheimer disease.